Abstract
Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) inhibited the binding of [ 3H]flunitrazepam (2 nM), [ 3H]muscimol (5 nM) and 4 nM [ 35S] t-butylbicyclophosphorothionate [ 35S]TBPS in the rat cerebellum as well as cerebral cortex. DHEAS-induced inhibition of binding of these radioligands (62% to 100%) was more pronounced as compared to that in the case of DHEA (5% to 31%). DHEAS, unlike DHEA, inhibited [ 3H]flunitrazepam binding significantly to a lesser extent in the cerebellum of ethanol-dependent rats as compared to the control group ( I max : 82±1 vs. 92±2% , p<0.005). However, DHEA, unlike DHEAS, inhibited [ 35S]TBPS binding to a greater extent in the ethanol-dependent rat cerebellum as compared to the control group ( I max : 31±2 vs. 19±2% , p<0.005). Furthermore, DHEA was more potent in inhibiting [ 35S]TBPS binding in the cerebellum (IC 50:55±5 vs. 74±7 μM, p<0.05) and cerebral cortex ( IC 50: 26±4 vs. 64±9 μM, p<0.05) of ethanol-dependent rats as compared to the control group. These observations indicate that unsulfated and sulfated androstane-steroids modulate the GABA A receptors in the control as well as the ethanol-dependent rats differentially, and also suggest that the androstane-steroid binding sites associated with the GABA A receptors play an important role during ethanol dependence.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
